World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02918838
Date of registration: 14/09/2016
Prospective Registration: No
Primary sponsor: RAND
Public title: Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize Drawing SATA
Scientific title: Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize Drawing
Date of first enrolment: August 2016
Target sample size: 216
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02918838
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Uganda
Contacts
Name:     Sebastian Linnemayr, PhD
Address: 
Telephone:
Email:
Affiliation:  RAND
Key inclusion & exclusion criteria

Inclusion Criteria:

- have been in HIV care at the clinic for at least three months

- are currently taking HIV-related medication (ART or co-trimoxazole)

- either own a phone or have regular access to one

- intend to stay at the clinic for the study period

- are not in boarding school (where phones are forbidden)

Exclusion Criteria:

- does not speak or understand either English or Luganda



Age minimum: 16 Years
Age maximum: 25 Years
Gender: All
Health Condition(s) or Problem(s) studied
Human Immunodeficiency Virus
Intervention(s)
Behavioral: Fixed Adherence Group
Behavioral: Control Group
Behavioral: Own Adherence Group
Primary Outcome(s)
Medication adherence rates using electronically monitored adherence (MEMS cap) data [Time Frame: 9 months after enrollment]
Secondary Outcome(s)
Fraction of clients displaying adherence of 90% or more [Time Frame: 9 months after enrollment]
Viral load assays [Time Frame: 9 months after enrollment]
Indicator for treatment interruptions of more than 48 hours [Time Frame: 9 months after enrollment]
Secondary ID(s)
3R01HD074925-04S1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history